Cancer treatment in conventional medicine—such as surgery, chemotherapy, radiation therapy, and targeted therapy—is selected based on the type of cancer and its stage. These approaches are guided by extensive clinical research, which has been compiled into clinical practice guidelines. These guidelines include statistical data on response rates, prognosis, survival probabilities, and potential side effects.
One of the most concerning aspects of cancer is that, statistically, most cancers in their early stages respond well to treatment and have higher survival rates compared to advanced or metastatic cancers. However, early-stage cancers often present with few or no symptoms and are difficult to detect using standard medical techniques. By the time symptoms appear, the disease is often no longer in its early stage, leading to poorer prognosis. As a result, symptomatic cancers tend to have higher mortality rates, making cancer a particularly feared diagnosis.
Why are chemotherapy and radiation alone not sufficient?
Chemotherapy and radiation therapy are powerful treatments that target rapidly dividing cancer cells. These therapies are designed to interfere with enzymes and mechanisms involved in cancer cell replication. However, they are not specifically designed to eliminate cancer stem cells—the root cells of cancer.
As a result, even after treatment, tumors may shrink, but cancer stem cells can remain. Some of these cells may evade treatment, adapt, and develop resistance to chemotherapy, leading to recurrence. Additionally, chemotherapy can affect normal cells, causing side effects such as low white blood cell counts, oral mucosal damage, ulcers, and hair loss. These effects contribute to patients’ fear of treatment.
The role of integrative medicine in cancer care
Integrative medicine complements conventional cancer treatment by combining scientific approaches with additional therapies aimed at improving outcomes. Beyond targeting cancer mechanisms with drugs, integrative approaches aim to eliminate residual cancer cells—including cancer stem cells—thereby increasing survival chances and the possibility of remission.
Integrative medicine takes a holistic, patient-centered approach. It incorporates lifestyle modifications, mind-body practices, natural products from various cultural traditions, and innovations from multiple medical disciplines. These approaches often align with functional medicine concepts, targeting underlying mechanisms of cancer while working alongside conventional treatments.
The goals include improving treatment response, increasing survival rates, reducing residual disease, lowering drug resistance, minimizing side effects, and enhancing quality of life—without interfering with primary medical treatments.
Examples of integrative approaches in cancer care
- Lifestyle Medicine
Diet, stress levels, daily activities, sleep quality, and environmental toxin exposure all affect gut microbiota, immune function, hormonal balance, and gene expression. These lifestyle factors are key contributors to cancer risk.
Physicians act as health coaches, guiding patients in lifestyle adjustments tailored to their treatment stage. Evidence shows that patients with healthier lifestyles tend to respond better to treatment and have improved survival rates.
- Nutraceuticals and Herbal Medicine
Research increasingly supports the use of nutrients and phytochemicals alongside conventional therapy to enhance immune function, target cancer cells, and reduce side effects.
Examples include:
* Medicinal mushrooms to boost immunity and reduce chemotherapy side effects
* Curcumin to reduce inflammation
* Protein supplementation during recovery
* Probiotics to balance gut microbiota
- Immunotherapy Approaches
These include targeted drugs, peptides, cancer vaccines, and cell-based therapies aimed at restoring and training the immune system to recognize and destroy cancer cells.
While checkpoint inhibitor drugs are effective, their response rates are limited. Combining them with cell-based therapies such as NK cell therapy may overcome immune suppression and significantly enhance treatment response.
- Metabolic Therapy for Cancer
This approach targets how cancer cells use nutrients. It involves non-chemotherapy drugs, often repurposed medications such as certain diabetes drugs, lipid-lowering drugs, or antiparasitic drugs, to disrupt cancer metabolism.
- Other Complementary Therapies
These include oxygen therapy, ozone therapy, hyperthermia (heat therapy), and lymphatic stimulation. These methods aim to modify the tumor microenvironment, inhibit cancer growth, enhance drug effectiveness, and support immune function.
Personalized treatment approach
Selecting appropriate integrative therapies requires careful evaluation by physicians. Each patient is assessed individually, including analysis of disease mechanisms and biomarkers from blood tests. This allows for personalized treatment planning tailored to the specific characteristics of the patient’s cancer
- Latte-Naor S, Mao JJ. Putting Integrative Oncology Into Practice: Concepts and Approaches. J Oncol Pract. 2019 Jan;15(1):7-14.
- O’Brien, K.; Ried, K.; Binjemain, T.; Sali, A. Integrative Approaches to the Treatment of Cancer. Cancers 2022, 14,
- Marino, P.; Mininni, M.; Deiana, G.; Marino, G.; Divella, R.; Bochicchio, I.; Giuliano, A.; Lapadula, S.; Lettini, A.R.; Sanseverino, F. Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer. Nutrients 2024, 16,
- Khan N, Afaq F, Mukhtar H. Lifestyle as risk factor for cancer: Evidence from human studies. Cancer Lett. 2010 Jul 28;293(2):133-43.
- Bian Z, Zhang R, Yuan S, Fan R, Wang L, Larsson SC, Theodoratou E, Zhu Y, Wu S, Ding Y, Li X. Healthy lifestyle and cancer survival: A multinational cohort study. Int J Cancer. 2024 May 15;154(10):1709-1718.
- Zoi V, Galani V, Lianos GD, Voulgaris S, Kyritsis AP, Alexiou GA. The Role of Curcumin in Cancer Treatment. Biomedicines. 2021 Aug 26;9(9):1086.
- Moon DO. Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management. Int J Mol Sci. 2024 Mar 2;25(5):2911.
- Narayanan S, de Mores AR, Cohen L, Anwar MM, Lazar F, Hicklen R, Lopez G, Yang P, Bruera E. Medicinal Mushroom Supplements in Cancer: A Systematic Review of Clinical Studies. Curr Oncol Rep. 2023 Jun;25(6):569-587.
- Baeza-Noci J, Pinto-Bonilla R. Systemic Review: Ozone: A Potential New Chemotherapy. Int J Mol Sci. 2021 Oct 30;22(21):11796.
- Li Y, Pu R. Ozone Therapy for Breast Cancer: An Integrative Literature Review. Integr Cancer Ther. 2024 Jan-Dec;23:15347354241226667.
- Clavo B, Navarro M, Federico M, Borrelli E, Jorge IJ, Ribeiro I, Rodríguez-Melcon JI, Caramés MA, Santana-Rodríguez N, Rodríguez-Esparragón F. Long-Term Results with Adjuvant Ozone Therapy in the Management of Chronic Pelvic Pain Secondary to Cancer Treatment. Pain Med. 2021 Sep 8;22(9):2138-2141.
- Moen I, Stuhr LE. Hyperbaric oxygen therapy and cancer–a review. Target Oncol. 2012 Dec;7(4):233-42.
- Canarslan Demir K, Avci AU, Ozgok Kangal MK, Ceylan B, Abayli SY, Ozler I, Yilmaz KB. Hyperbaric Oxygen Therapy for Managing Cancer Treatment Complications: A Safety Evaluation. Medicina (Kaunas). 2025 Feb 22;61(3):385.
- Mink van der Molen DR, Batenburg MCT, Maarse W, van den Bongard DHJG, Doeksen A, de Lange MY, van der Pol CC, Evers DJ, Lansdorp CA, van der Laan J, van de Ven PM, van der Leij F, Verkooijen HM. Hyperbaric Oxygen Therapy and Late Local Toxic Effects in Patients With Irradiated Breast Cancer: A Randomized Clinical Trial. JAMA Oncol. 2024 Apr 1;10(4):464-474.
- Yi GY, Kim MJ, Kim HI, Park J, Baek SH. Hyperthermia Treatment as a Promising Anti-Cancer Strategy: Therapeutic Targets, Perspective Mechanisms and Synergistic Combinations in Experimental Approaches. Antioxidants (Basel). 2022 Mar 24;11(4):625.
- Palazzi M, Maluta S, Dall’Oglio S, Romano M. The role of hyperthermia in the battle against cancer. Tumori. 2010 Nov-Dec;96(6):902-10.
- Smadja DM. Hyperthermia for Targeting Cancer and Cancer Stem Cells: Insights from Novel Cellular and Clinical Approaches. Stem Cell Rev Rep. 2024 Aug;20(6):1532-1539.
- Hynynen K, Lulu BA. Hyperthermia in cancer treatment. Invest Radiol. 1990 Jul;25(7):824-34.
- Portale F, Di Mitri D. NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential. Int J Mol Sci. 2023 May 30;24(11):9521.
- Park H, Kim G, Kim N, Ha S, Yim H. Efficacy and safety of natural killer cell therapy in patients with solid tumors: a systematic review and meta-analysis. Front Immunol. 2024 Oct 16;15:1454427.
- Page A, Chuvin N, Valladeau-Guilemond J, Depil S. Development of NK cell-based cancer immunotherapies through receptor engineering. Cell Mol Immunol. 2024 Apr;21(4):315-331.
- Du N, Guo F, Wang Y, Cui J. NK Cell Therapy: A Rising Star in Cancer Treatment. Cancers (Basel). 2021 Aug 17;13(16):4129.
- Wolf E, Milazzo S, Boehm K, Zwahlen M, Horneber M. Thymic peptides for treatment of cancer patients. Cochrane Database Syst Rev. 2011 Feb 16;2011(2):CD003993.
- Savino W, Lepletier A. Thymus-derived hormonal and cellular control of cancer. Front Endocrinol (Lausanne). 2023 Jul 17;14:1168186.
- Schulof RS. Thymic peptide hormones: basic properties and clinical applications in cancer. Crit Rev Oncol Hematol. 1985;3(4):309-76.
- Inui T, Kuchiike D, Kubo K, Mette M, Uto Y, Hori H, Sakamoto N. Clinical experience of integrative cancer immunotherapy with GcMAF. Anticancer Res. 2013 Jul;33(7):2917-9.
- Saburi E, Saburi A, Ghanei M. Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside. Caspian J Intern Med. 2017 Fall;8(4):228-238.
- Pacini S, Morucci G, Punzi T, Gulisano M, Ruggiero M. Gc protein-derived macrophage-activating factor (GcMAF) stimulates cAMP formation in human mononuclear cells and inhibits angiogenesis in chick embryo chorionallantoic membrane assay. Cancer Immunol Immunother. 2011 Apr;60(4):479-85.
- Yamamoto N, Suyama H, Yamamoto N. Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF. Transl Oncol. 2008 Jul;1(2):65-72.
